Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018166

Expand all

TRASICOR (OXPRENOLOL HYDROCHLORIDE)
20MG
Marketing Status: Discontinued

Active Ingredient: OXPRENOLOL HYDROCHLORIDE
Proprietary Name: TRASICOR
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018166
Product Number: 001
Approval Date: Dec 28, 1983
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRASICOR (OXPRENOLOL HYDROCHLORIDE)
40MG
Marketing Status: Discontinued

Active Ingredient: OXPRENOLOL HYDROCHLORIDE
Proprietary Name: TRASICOR
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018166
Product Number: 002
Approval Date: Dec 28, 1983
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRASICOR (OXPRENOLOL HYDROCHLORIDE)
80MG
Marketing Status: Discontinued

Active Ingredient: OXPRENOLOL HYDROCHLORIDE
Proprietary Name: TRASICOR
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018166
Product Number: 003
Approval Date: Dec 28, 1983
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRASICOR (OXPRENOLOL HYDROCHLORIDE)
160MG
Marketing Status: Discontinued

Active Ingredient: OXPRENOLOL HYDROCHLORIDE
Proprietary Name: TRASICOR
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 160MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018166
Product Number: 004
Approval Date: Dec 28, 1983
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information